Health Care Services

CVS Health

CVS Health Reaffirms Commitment to Military Community, Plans $292M Investment in 2025

Gamco Investors Reduces CVS Health Stake by 11.6% and Sells Nearly 15,000 Shares

North Dakota Investment Board Increases CVS Holdings as Q1 Earnings Beat Expectations

CVS Health Joins CNCF as Platinum Member to Optimize Tech Architecture

DNB Asset Management Increases CVS Stake by 17.6%, Analysts Upgrade to Buy

World Investment Advisory and others significantly increase CVS Health holdings as earnings beat expectations

CVS Health Corporation's average stock price target raised to $100.12

CVS Health Wins Dual AI Awards at the 2026 Stevie Awards

Bernstein Raises CVS Health Target Price to $106

CVS Health's EVP Tilak Mandadi sells company stocks

Mizuho Analyst Reiterates Buy Rating on CVS Health With Price Target

Swiss Bank Raises CVS Health's Target Price to $100 and Maintains Buy Rating

CVS Health and Hartford HealthCare Partner to Offer Adult Primary Care Services

Barclays analyst maintains buy rating on CVS Health

CVS Health's Lower Medical Cost Ratio Lifts Profit and Outlook

CVS Health released FY2026 Q1 earnings on May 6 Pre-Market (EST), actual revenue USD 99.85 B (forecast USD 95.02 B), actual EPS USD 2.3 (forecast USD 1.9251)

CVS Health Executives Report Customers Halting Coverage for GLP-1 Drugs

Cvs Announces Expansion of Biosimilar Drug Use

CVS Health Adjusts Prescription Drug List to Lower Costs

Strs Ohio Reduces Holdings in CVS Health

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

Silexion Therapeutics

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

MetaVia

Pinned News

置顶新闻

CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started?

CVS Health Corporation (CVS.US) Q1 2026 Earnings Conference Call

CVS Health Corporation (CVS.US) Q4 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) Q2 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) Q1 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) 2024 Q4 Earnings Conference Call

CVS Health's stock has surged 24% following a strong first-quarter earnings report, with revenue up 6.2% to $100.4 billion and EPS rising 62% to $2.30. The company raised its full-year guidance and offers an attractive dividend yield of 2.8%. Despite concerns over high debt of $86.4 billion, CVS is improving profitability and analysts project a price target of $101.58. However, it was not included in a list of top stock recommendations by The Motley Fool.

nasdaq

NVIDIA

Intel

Walgreens Boots Alliance

Humana

Netflix

S&P 500

NVIDIA Corporation

Treasury Prime has launched Prime Cash, a solution enabling fintech companies to allow customers to deposit cash at over 90,000 retail locations in the US, including Walmart and CVS. This service addresses the needs of customers who primarily use cash, providing a convenient way to convert it into digital funds without visiting a bank branch.

- Treasury Prime has launched Prime Cash in San Francisco, enabling fintech companies to accept cash deposits at over 90,000 retail locations nationwide.  
- This service allows customers to convert cash into digital funds without needing to visit a bank branch.  
- It addresses the needs of customers who primarily rely on cash despite the dominance of digital payment methods like ACH and card transactions.

Unusual Whales

Walmart

SPDR S&P Retail ETF

VanEck Retail ETF

Seven & I Holdings Co., Ltd.

Seven & i Holdings Co., Ltd.

Treasury Prime Launches Prime Cash For Nationwide Cash Deposits

CVS Health reaffirms its commitment to supporting service members, veterans, and their families through comprehensive health care access, community solutions, and economic opportunities. The company collaborates with various organizations to address the unique challenges faced by military-connected individuals, enhancing access to care and fostering stability. CVS Health also invests in workforce development and entrepreneurship for veterans, spending $292 million with veteran small businesses in 2025, demonstrating its ongoing support for the military community.

prnewswire

08:30 ETCVS Health Reinforces Longstanding Support for the Military Community

Gamco Investors INC. ET AL reduced its stake in CVS Health Corporation by 11.6%, selling 14,768 shares during the 4th quarter. After the sale, it holds 112,713 shares valued at approximately $8.95 million. Other institutional investors have also adjusted their positions in CVS Health, with significant increases noted. CVS Health's stock has a consensus rating of 'Moderate Buy' with an average price target of $98.08.

Market Beat

GAMCO Investors, Inc.

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS

ABBV

AbbVie and CVS Health appear expensive with trailing P/E multiples over 40, but non-recurring expenses inflate these figures. AbbVie’s forward P/E is 15, while CVS Health’s is 13, indicating they may be undervalued. AbbVie faced a significant drop in net income due to a $2.7 billion charge, while CVS reported a $4 billion loss from goodwill impairment. Both companies show potential for better performance, making them attractive investment options despite their current valuations.

Abbvie

VanEck Biotech ETF

SPDR S&P Biotech

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Health Care Select Sector SPDR

iShares Global Healthcare

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

VG Health

2 Stocks That Are Much Cheaper Than They Look

Bill Allison, a 65-year-old military veteran, underwent a heart transplant after two heart attacks and years of smoking. With support from his CVS Specialty pharmacist, he made significant lifestyle changes and emphasizes the importance of medication adherence and ongoing care. Now 81, he advocates for organ donation and encourages others to listen to their healthcare teams for a second chance at life.

MorningStar

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

The majority of participants in a recent survey expressed that their limited digital literacy skills are affecting their health management negatively. CVS Health is actively introducing new digital tools to assist members in accessing medical services. This effort is part of the company's massive $20 billion technology plan revealed in 2025.

CVS Health study reveals a need for greater digital health literacy for Medicare members

CVS Health(CVS.US)